You have successfully sign out
Loading...
Neuphoria Therapeutics Inc.
NEUP
Company Description
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.
Â
NASDAQ
15.17USD
-2.07Â ( -12.01%)
After-hours 15.17$
0.00 (0.00%)Market Closed (as of Oct 16, 20:00 EDT)
Relative Strenght
91
Volume Buzz
-6%
Earning Acce
No
Dist 52w H.
29%
